Endoscopic Recognition and Classification of Colorectal Polyps.

Autor:	Mareth K; Veterans Affairs Medical Center, 921 NE 13th St, Oklahoma City, OK 73104, USA; Gastroenterology and Hepatology, Division of Digestive Diseases and Nutrition, University of Oklahoma Health Sciences Center, 800 Stanton L. Young Boulevard, COMD 7400, Oklahoma City, OK 73104, USA., Gurm H; Veterans Affairs Medical Center, 921 NE 13th St, Oklahoma City, OK 73104, USA; Gastroenterology and Hepatology, Division of Digestive Diseases and Nutrition, University of Oklahoma Health Sciences Center, 800 Stanton L. Young Boulevard, COMD 7400, Oklahoma City, OK 73104, USA., Madhoun MF; Veterans Affairs Medical Center, 921 NE 13th St, Oklahoma City, OK 73104, USA; Gastroenterology and Hepatology, Division of Digestive Diseases and Nutrition, University of Oklahoma Health Sciences Center, 800 Stanton L. Young Boulevard, COMD 7400, Oklahoma City, OK 73104, USA. Electronic address: mohammad-madhoun@ouhsc.edu.
Jazyk:	angličtina
Zdroj:	Gastrointestinal endoscopy clinics of North America [Gastrointest Endosc Clin N Am] 2022 Apr; Vol. 32 (2), pp. 227-240. Date of Electronic Publication: 2022 Feb 22.
DOI:	10.1016/j.giec.2021.12.003
Abstrakt:	Colonoscopy allows the performing endoscopist to thoroughly evaluate superficial colon lesions based on morphologic features such as size, location, shape, and surface pattern and also perform endoscopic resection where appropriate. Different elements of polyp characterization have been incorporated into systems that standardize this evaluation process and elucidate the likelihood of submucosal invasion or malignancy. Lesions which have invaded the submucosa are more likely to metastasize and are often not appropriate for endoscopic resection. It is, therefore, essential for the proceduralist to understand the multiple elements of lesion characterization and how they fit into the existing classification schemes. Competing Interests: Conflict of interest The authors of this article report no conflicts of interest, including consulting fees, paid expert testimony, employment, grants, honoraria, patents, royalties, stocks, or other financial or material gains that may involve the subject matter. (Copyright © 2021 Elsevier Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu